Nautilus Biotechnology: Funding, Investors & Team (Oct 2026)
Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
Nautilus Biotechnology has raised $76.0M across 1 funding round on record, the most recent an undisclosed round of $76.0M announced in May 2020.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nautilus Biotechnology Company Profile and Key Stats
Latest funding round on record: May 2020.
Nautilus Biotechnology Funding Rounds
Nautilus Biotechnology Founders and Leadership Team
Contact details for the Nautilus Biotechnology team: 1 of 1 has an email address on file.
Start 14-day free trial →Nautilus Biotechnology Funding Compared to Other Biotechnology Startups
Nautilus Biotechnology's latest round of $76.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nautilus Biotechnology in Biotechnology and San Carlos
Companies Similar to Nautilus Biotechnology
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Nautilus Biotechnology Funding FAQs
What does Nautilus Biotechnology do?
Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
How much funding has Nautilus Biotechnology raised?
Nautilus Biotechnology has raised $76.0M across 1 round on record. The most recent is an undisclosed round of $76.0M announced in May 2020.
When did Nautilus Biotechnology last raise funding?
Nautilus Biotechnology's most recent funding round on record is an undisclosed round of $76.0M, announced in May 2020.
Who is the CEO of Nautilus Biotechnology?
Sujal Patel is listed as CEO at Nautilus Biotechnology.
Where is Nautilus Biotechnology headquartered?
Nautilus Biotechnology is based in San Carlos, California, United States.
How many employees does Nautilus Biotechnology have?
Nautilus Biotechnology is in the 51-100 employee band.
How does Nautilus Biotechnology's funding compare to other Biotechnology startups?
Nautilus Biotechnology's latest round of $76.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nautilus Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nautilus Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.